Navigation Links
New drug compound to treat Alzheimer’s diseas

Professor Martin Watterson and team from Northwestern University, Feinberg School of Medicine have found a new compound called MW01-5-188WH which has been found// to inhibit the production of the immune cells Cytokines which leads to activation of glia, which is responsible for causing inflammation in brain cells leading to neuron loss leading to degeneration of brain cells in Alzheimer’s disease.

Alzheimer’s disease is characterized by loss in memory due to damage to brain cells which leads to loss of memory, reasoning ability and the capacity to read and understand decreases, they become increasingly forgetting, disoriented in their approach and will develop problems in solving mathematical problems. The researchers found that this compound inhibits cytokines not leading to neurodegenerative diseases in animal models and the researchers are planning to do a clinical trial on human trials which would prove the efficacy of the drug
'"/>




Page: 1

Related medicine news :

1. Brain cells protected by new compounds
2. Body compounds can protect you against pain
3. Implantable devices to be powered by organosilicon compounds in the future
4. New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders
5. Garlic compound may help treat cancer
6. Thyroid hormone treatment hastens recovery after cardiac surgery
7. Feeding channel created by malaria parasite - a new target for malaria treatments
8. New drug to treat Heart Attack and damaged tissue
9. Now umbilical cord helps in stroke treatment.
10. Now AIDS treatment comes dirt-cheap
11. Breast cancer treatment to be determined by gene test
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: